Jul 11 |
3 Underappreciated Stocks About to Break Their Chains
|
Jul 11 |
Is Gilead Sciences (NASDAQ:GILD) A Risky Investment?
|
Jul 9 |
7 Cheap Biotech Stocks With Major Upside Potential
|
Jul 8 |
Gilead Gets Analyst Upgrade on 'Outstanding' HIV Treatment Data
|
Jul 8 |
This Domino's Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
|
Jul 8 |
Gilead (GILD) Loses 17.6% YTD: How Should You Play the Stock?
|
Jul 8 |
Gilead Sciences upgraded to Outperform by Raymond James
|
Jul 3 |
5 FDA decisions to watch in the third quarter
|
Jul 2 |
Should You Be Concerned About Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE?
|
Jul 2 |
Insider Sale: Chief Medical Officer Merdad Parsey Sells Shares of Gilead Sciences Inc (GILD)
|